Profil
Actuellement, Naveed K. Shams occupe le poste de Chief Scientific Officer, General Manager-R&D chez Santen Pharmaceutical Co., Ltd, Chairman chez InnFocus, Inc. (une filiale de Santen Pharmaceutical Co., Ltd.) et de directeur scientifique de ProQR Therapeutics NV. Au cours de sa carrière, il a occupé les postes de CMO, de vice-président principal de la recherche et du développement chez OPKO Health, Inc, de scientifique principal et de chef du groupe Glaucome-Discovery chez Storz Ophthalmics, Inc, de président, de directeur général et de directeur chez Santen, Inc, de directeur médical principal chez Genentech, Inc, de directeur des sciences cliniques chez Novartis Ophthalmics, Inc et de membre de la faculté de recherche du Schepens Eye Research Institute. Naveed K. Shams a obtenu un diplôme d'études supérieures du Dow Medical College et un doctorat de l'université de Caroline du Sud.
Postes actifs de Naveed Shams
| Sociétés | Poste | Début |
|---|---|---|
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology Provides next generation products for glaucoma surgery | Président | - |
Anciens postes connus de Naveed Shams
| Sociétés | Poste | Fin |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
| OPKO HEALTH, INC. | Directeur Technique/Scientifique/R&D | 10/06/2009 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | 01/11/2007 |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Directeur Technique/Scientifique/R&D | 01/09/2003 |
Storz Ophthalmics, Inc. | Corporate Officer/Principal | 01/03/1998 |
Formation de Naveed Shams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Santen Pharmaceutical Co., Ltd.
Santen Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales prescription drugs & medical devices to treat ophthalmology diseases | Health Technology |
University of South Carolina
University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Schepens Eye Research Institute, Inc.
The Schepens Eye Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical ophthalmology research enterprise | Commercial Services |
Santen, Inc.
Santen, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic products | Health Technology |
OPKO Health, Inc.
OPKO Health, Inc. Medical/Nursing ServicesHealth Services Engages in biopharmaceutical and diagnostics | Health Services |
Storz Ophthalmics, Inc. | |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Health Technology |
InnFocus, Inc.
InnFocus, Inc. BiotechnologyHealth Technology Provides next generation products for glaucoma surgery | Health Technology |
ProQR Therapeutics NV
ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
Dow Medical College
Dow Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















